TCL Archive Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research September 13, 1996
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment. April 25, 2008
TCL Archive NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training November 27, 1998
